Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China
· Delayed Price · Currency is CNY 73.17
-1.28 (-1.72%)
Apr 29, 2026, 3:00 PM CST
SHA:688336 Revenue
Sunshine Guojian Pharmaceutical (Shanghai) had revenue of 431.23M CNY in the quarter ending March 31, 2026, with 38.61% growth. This brings the company's revenue in the last twelve months to 4.32B, up 248.95% year-over-year. In the year 2025, Sunshine Guojian Pharmaceutical (Shanghai) had annual revenue of 4.20B with 251.81% growth.
Revenue (ttm)
4.32B
Revenue Growth
+248.95%
P/S Ratio
10.65
Revenue / Employee
4.27M
Employees
1,012
Market Cap
46.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.20B | 3.01B | 251.81% |
| Dec 31, 2024 | 1.19B | 179.53M | 17.70% |
| Dec 31, 2023 | 1.01B | 188.54M | 22.84% |
| Dec 31, 2022 | 825.49M | -103.32M | -11.12% |
| Dec 31, 2021 | 928.81M | 273.80M | 41.80% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharmaron Beijing | 14.10B |
| Beijing Wantai Biological Pharmacy Enterprise | 1.82B |
| Asymchem Laboratories (Tianjin) | 6.67B |
| Shanghai Allist Pharmaceuticals | 5.67B |
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Shanghai RAAS Blood Products | 7.35B |
| Chongqing Zhifei Biological Products | 10.91B |
| Haisco Pharmaceutical Group | 5.06B |